HLAVNÍ TÉMA Dnešní pohled na dědičné trombofilie 492 | VNITŘNÍ LÉKAŘSTVÍ / Vnitř Lék. 2022;68(8):488-492 / www.casopisvnitrnilekarstvi.cz 13. Kyrle PA, Kammer M, Eischer L et al. The long‑term recurrence risk of patients with unprovoked venous thromboembolism: an observational cohort study. J Thromb Haemost. 2016;14(12):2402-2409. 14. Jiménez D, Díaz G, Marín E et al. The risk of recurrent venous thromboembolism in patients with unprovoked symptomatic deep vein thrombosis and asymptomatic pulmonary embolism. Thromb Haemost. 2006;95(3):562-566. 15. Kearon C. Extended anticoagulation for unprovoked venous thromboembolism: a majority of patients should be treated. J Thromb Thrombolysis. 2011;31(3):295-300. 16. Barco S, Corti M, Trinchero A et al. Survival and recurrent venous thromboembolism in patients with first proximal or isolated distal deep vein thrombosis and no pulmonary embolism. J Thromb Haemost. 2017;15(7):1436-1442. 17. Rosendaal F. Venouds thrombosis: a multicausal disease. Lancet. 199;353:1167-1173. 18. Margaglione M, Grandone E. Population genetics of venous thromboembolism. A narrative review. Thromb Haemost. 2011;105(2):221-31. 19. Zöller B, Li X, Ohlsson H et al. Family history of venous thromboembolism as a risk factor and genetic research tool. Thromb Haemost. 2015;114(5):890-900. 20. Mannucci PM, Franchini M. Classic thrombophilic gene variants. Thromb Haemost. 2015;114(5):885-9. 21. Egeberg O. Inherited antithrombin deficiency causing thrombophilia. Thromb.Diath. Haemorrh 1965;13:516-530. 22. Griffin JH, Evatt B, Zimmerman TS et al. Deficiency of protein C in congenital thrombotic disease. J Clin Invest 1981;68:1370-1373. 23. Schwartz, HP, Fisher M, Hopmeier P et al. Plasma protein S deficiency in familal thrombotic disease. Blood. 1984;64:1297-1300. 24. Giri TK, Yamazaki T, Sala N et al. Deficient APC‑cofactor activity of protein S Heerlen in degradation of factor Va Leiden: a possible mechanism of synergism between thrombophilic risk factors. Blood. 2000;96:523-531. 25. Bertina RM, Koeleman BP, Koster T et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature. 1994;369:64-67. 26. Poort SR, Rosendaal FR, Reitsma PH et al. A common genetic variation in the 3’- untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood. 1996;88:3698-3703. 27. Manderstedt E, Lind‑Halldén C, Halldén C et al. Classic thrombophilias and thrombotic risk among middle‑aged and older adults: a population‑based cohort study. J Am Heart Assoc. 2022;11(4): e023018. DOI: 10.1161/JAHA.121.023018. 28. Manolio TA:Genomewide association studies and assessment of the risk of disease. N Engl J Med. 2010;363:166-76. 29. Bezemer ID, Bare LA, Doggen CJ et al. Gene variants associated with deep vein thrombosis. JAMA 2008; 299:1306-1314. 30. Trégouët DA, Heath S, Saut N et al. Common susceptibility alleles are unlikely to contribute as strongly as the FV and ABO loci to VTE risk: results from a GWAS approach. Blood 2009;113(21):5298-5303. 31. Tang W, Teichert M, Chasman DI et al. A genome‑wide association study for venous thromboembolism: the extended cohorts for heart and aging research in genomic epidemiology (CHARGE) consortium. Genet Epidemiol. 2013;37(5):512-521. 32. Lindström S, Wang L, Smith EN et al. Genomic and transcriptomic association studies identify 16 novel susceptibility loci for venous thromboembolism. Blood. 2019;134 (19):1645-1657. 33. Klarin D, Busenkell E, Judy R et al. Genome‑wide association analysis of venous thromboembolism identifies new risk loci and genetic overlap with arterial vascular disease. Nat Genet. 2019;51(11):1574-1579. 34. Zöller B, Svensson PJ, Dahlbäck B et al. Genetic risk factors for venous thromboembolism. Expert Rev Hematol. 2020;13(9):971-981. 35. Vrtel P, Slavik L, Vodicka R et al. Detection of unknown and rare pathogenic variants in antithrombin, protein C and protein S deficiency using high‑throughput targeted sequencing. Diagnostics (Basel) 2022;12(5):1060. DOI: 10.3390 /diagnostics12051060. 36. de Haan HG, Bezemer ID, Doggen CJ et al. Multiple SNP testing improves risk prediction of first venous thrombosis. Blood. 2012;120(3):656-663. 37. van Hylckama Vlieg A, Flinterman LE, Bare LA et al. Genetic variations associated with recurrent venous thrombosis. Circ Cardiovasc Genet. 2014;7(6):806-13. 38. Kolin DA, Kulm S, Elemento O. Prediction of primary venous thromboembolism based on clinical and genetic factors within the U.K. Biobank. Sci Rep. 2021;11(1):21340. Erratum in: Sci Rep. 2021;11(1):23364. 39. Clifton L, Collister JA, Liu X et al. Assessing agreement between different polygenic risk scores in the UK Biobank. Sci Rep. 2022;12(1):12812. 40. Choi SW, Mak TS, O‚Reilly PF. Tutorial: a guide to performing polygenic risk score analyses. Nat Protoc. 2020;15(9):2759-2772. Vnitřní lékařství Předplatné časopisu Už máte předplaceno? ROČNÍK 69 2023 OBJEDNÁVEJTE www.casopisvnitrnilekarstvi.cz predplatne@solen.cz SUPPLEMENTA A ODBORNÉ PUBLIKACE TIŠTĚNÝ ČASOPIS 8 čísel / rok ROZŠÍŘENÁ E VERZE na www.casopisvnitrnilekarstvi.cz FANDÍME MLADÝM LÉKAŘŮM, a proto předplatitelé do 35 let získají 50% SLEVU Spojili jsme sí ly Interní medicína pro praxi a Vnitřní lékařství pod jednou hlavičkou diabetologie pro praxi 26. 1. 2023 HOTEL FLORA, OLOMOUC 1. S předplatným časopisu Vnitřní lékařství na rok 2023 získáte nárok na 50% slevu z registračního poplatku na nový kongres Diabetologie pro praxi (26. 1. 2023 v Olomouci). www.diabetologiepropraxi.cz
RkJQdWJsaXNoZXIy NDA4Mjc=